|
|
||||||||
Journal of General Virology, Vol 78, 147-152, Copyright © 1997 by Society for General Microbiology
ARTICLES |
K Ibuki, SI Funahashi, H Yamamoto, M Nakamura, T Igarashi, T Miura, E Ido, M Hayami and H Shida
Institute for Virus Research, Kyoto University, Japan.
To develop effective vaccines against infection with human T cell leukaemia virus type I (HTLV-I), we constructed a recombinant vaccinia virus (WR-SFB5env) synthesizing the HTLV-I envelope (Env) gp46 protein under the control of a strong promoter, termed the ATI hybrid promoter. WR-SFB5env expressed a large quantity of gp46. In cynomolgus monkeys (Macaca fascicularis) immunized with WR-SFB5env, anti-HTLV-I Env antibody, including neutralizing antibody, was induced and remained at a high level until 136 weeks (2-6 years) post-infection (p.i.). These immunized monkeys had HTLV-I Env-specific cytotoxic T lymphocyte activity. At 136 weeks p.i., the immunized monkeys were challenged with an HTLV-I-producing cynomolgus T lymphocyte cell line. Neither HTLV-I antigen nor HTLV-I proviruses were detected in peripheral blood mononuclear cells, lymph nodes or spleens of the WR-SFB5env-immunized monkeys, in contrast to non-immunized control monkeys. These results indicate that a single immunization with WR-SFB5env induced prolonged humoral and cellular immune responses to HTLV-I and protected the monkeys against virus challenge.
This article has been cited by other articles:
![]() |
A. Mirsaliotis, K. Nurkiyanova, D. Lamb, J. M. Woof, and D. W. Brighty Conformation-Specific Antibodies Targeting the Trimer-of-Hairpins Motif of the Human T-Cell Leukemia Virus Type 1 Transmembrane Glycoprotein Recognize the Viral Envelope but Fail To Neutralize Viral Entry J. Virol., June 1, 2007; 81(11): 6019 - 6031. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kazanji, J.-M. Heraud, F. Merien, C. Pique, G. de The, A. Gessain, and S. Jacobson Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus). J. Gen. Virol., May 1, 2006; 87(Pt 5): 1331 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hakata, M. Yamada, and H. Shida Rat CRM1 Is Responsible for the Poor Activity of Human T-Cell Leukemia Virus Type 1 Rex Protein in Rat Cells J. Virol., December 1, 2001; 75(23): 11515 - 11525. [Abstract] [Full Text] |
||||
![]() |
M. Kazanji, J. Tartaglia, G. Franchini, B. de Thoisy, A. Talarmin, H. Contamin, A. Gessain, and G. de The Immunogenicity and Protective Efficacy of Recombinant Human T-Cell Leukemia/Lymphoma Virus Type 1 NYVAC and Naked DNA Vaccine Candidates in Squirrel Monkeys (Saimiri sciureus) J. Virol., July 1, 2001; 75(13): 5939 - 5948. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mortreux, M. Kazanji, A.-S. Gabet, B. de Thoisy, and E. Wattel Two-Step Nature of Human T-Cell Leukemia Virus Type 1 Replication in Experimentally Infected Squirrel Monkeys (Saimiri sciureus) J. Virol., January 15, 2001; 75(2): 1083 - 1089. [Abstract] [Full Text] |
||||
![]() |
M. Kazanji, A. Ureta-Vidal, S. Ozden, F. Tangy, B. de Thoisy, L. Fiette, A. Talarmin, A. Gessain, and G. de Thé Lymphoid Organs as a Major Reservoir for Human T-Cell Leukemia Virus Type 1 in Experimentally Infected Squirrel Monkeys (Saimiri sciureus): Provirus Expression, Persistence, and Humoral and Cellular Immune Responses J. Virol., May 15, 2000; 74(10): 4860 - 4867. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |